These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 17918142)

  • 21. A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy.
    Matsunaga A; Sasaki J; Komatsu T; Kanatsu K; Tsuji E; Moriyama K; Koga T; Arakawa K; Oikawa S; Saito T; Kita T; Doi T
    Kidney Int; 1999 Aug; 56(2):421-7. PubMed ID: 10432380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of a novel 3-amino acid deletion mutation of apolipoprotein E (Apo E Tokyo) with lipoprotein glomerulopathy.
    Konishi K; Saruta T; Kuramochi S; Oikawa S; Saito T; Han H; Matsunaga A; Sasaki J
    Nephron; 1999; 83(3):214-8. PubMed ID: 10529627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoprotein glomerulopathy associated with psoriasis vulgaris: report of 2 cases with apolipoprotein E3/3.
    Chang CF; Lin CC; Chen JY; Yang AH; Shiao MS; Kao JT; Yang WC
    Am J Kidney Dis; 2003 Sep; 42(3):E18-23. PubMed ID: 12955707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein E Sendai (arginine 145-->proline): a new variant associated with lipoprotein glomerulopathy.
    Oikawa S; Matsunaga A; Saito T; Sato H; Seki T; Hoshi K; Hayasaka K; Kotake H; Midorikawa H; Sekikawa A; Hara S; Abe K; Toyota T; Jingami H; Nakamura H; Sasaki J
    J Am Soc Nephrol; 1997 May; 8(5):820-3. PubMed ID: 9176854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A complete genomic analysis of the apolipoprotein E gene in Chinese patients with lipoprotein glomerulopathy.
    Chen S; Liu ZH; Zheng JM; Zhang X; Li LS
    J Nephrol; 2007; 20(5):568-75. PubMed ID: 17918142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Etiological significance of apolipoprotein E mutations in lipoprotein glomerulopathy.
    Saito T; Ishigaki Y; Oikawa S; Yamamoto TT
    Trends Cardiovasc Med; 2002 Feb; 12(2):67-70. PubMed ID: 11852253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipoprotein glomerulopathy in China.
    Chen Y
    Clin Exp Nephrol; 2014 Apr; 18(2):218-9. PubMed ID: 24165683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases.
    Saito T; Matsunaga A; Oikawa S
    Am J Kidney Dis; 2006 Feb; 47(2):199-211. PubMed ID: 16431249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A possible structural basis behind the pathogenic role of apolipoprotein E hereditary mutations associated with lipoprotein glomerulopathy.
    Stratikos E; Chroni A
    Clin Exp Nephrol; 2014 Apr; 18(2):225-9. PubMed ID: 24149834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein E-related glomerular disorders.
    Saito T; Matsunaga A; Fukunaga M; Nagahama K; Hara S; Muso E
    Kidney Int; 2020 Feb; 97(2):279-288. PubMed ID: 31874799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipoprotein glomerulopathy: a new apolipoprotein E mutation with enhanced glomerular binding.
    Sam R; Wu H; Yue L; Mazzone T; Schwartz MM; Arruda JA; Dunea G; Singh AK
    Am J Kidney Dis; 2006 Mar; 47(3):539-48. PubMed ID: 16490634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenesis, histopathologic findings and treatment modalities of lipoprotein glomerulopathy: A review.
    Cambruzzi E; Pêgas KL
    J Bras Nefrol; 2019; 41(3):393-399. PubMed ID: 30421781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein E mutations: a comparison between lipoprotein glomerulopathy and type III hyperlipoproteinemia.
    Matsunaga A; Saito T
    Clin Exp Nephrol; 2014 Apr; 18(2):220-4. PubMed ID: 24570178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topics in lipoprotein glomerulopathy: an overview.
    Saito T; Matsunaga A; Ito K; Nakashima H
    Clin Exp Nephrol; 2014 Apr; 18(2):214-7. PubMed ID: 24149835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Updated Review and Meta Analysis of Lipoprotein Glomerulopathy.
    Li MS; Li Y; Liu Y; Zhou XJ; Zhang H
    Front Med (Lausanne); 2022; 9():905007. PubMed ID: 35602473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein E and renal disease.
    Liberopoulos E; Siamopoulos K; Elisaf M
    Am J Kidney Dis; 2004 Feb; 43(2):223-33. PubMed ID: 14750087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Lipoprotein glomerulopathy].
    Oikawa S
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():353-60. PubMed ID: 11347095
    [No Abstract]   [Full Text] [Related]  

  • 38. Lipoprotein glomerulopathy. Report of a normolipidemic case and review of the literature.
    Saito T; Sato H; Oikawa S; Kudo K; Kurihara I; Nakayama K; Abe K; Yoshinaga K; Sakaguchi H
    Am J Nephrol; 1993; 13(1):64-8. PubMed ID: 8322843
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.